CFI-400437 structure
|
Common Name | CFI-400437 | ||
---|---|---|---|---|
CAS Number | 1169211-37-3 | Molecular Weight | 492.57 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C29H28N6O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CFI-400437CFI-400437 is an indolinone-derived, ATP-competitive kinase inhibitor with high selectivity for PLK4 (IC50 of 0.6 nM)[1]. |
Name | CFI-400437 |
---|
Description | CFI-400437 is an indolinone-derived, ATP-competitive kinase inhibitor with high selectivity for PLK4 (IC50 of 0.6 nM)[1]. |
---|---|
Related Catalog | |
In Vitro | CFI-400437 is a potent inhibitor of MCF-7, MDA-MB-468 and MDA-MB231 cell growth[1]. CFI-400437 inhibits Aurora A, Aurora B, KDR and FLT-3 with IC50s of 0.37, 0.21, 0.48, and 0.18 µM, respectively, i.e. two orders of magnitude higher than its IC50 of 0.6 nM against PLK4[1]. CFI-400437 inhibits both AURKB and AURKC at concentrations <15 nM[2]. |
In Vivo | CFI-400437 (25 mg/kg, ip, once daily for 21 d) exhibits antitumor activity against MDA-MB-468 breast cancer mouse xenograft model[1]. |
References |
Molecular Formula | C29H28N6O2 |
---|---|
Molecular Weight | 492.57 |